Are MDMs cost effective? Advantages of MDMs
There were two non-randomised studies that reported results of
MDMs in cancer care
:
•
Fader et al (1998): with
melanoma
,
the costs of health
care were 33% to 50% lower
in patients whose
management decisions were made by an MDM
•
Hagiwara et al. (2011): team for patients with
haematologic
malignancies
.
It was found that incidences of hepatic
complications, hyperglycemia, and central venous catheter
infection were lower in the ‘after’ group than in the ‘before’
group, and
costs fell by about 20%